Inga Möller

TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma

Klaus Griewank, Rajmohan Murali, Joan Anton Puig‐Butillé et al. · JNCI Journal of the National Cancer Institute · 2014 · 251 citations · Full text

Enhancing Virus-Specific Immunity In Vivo by Combining Therapeutic Vaccination and PD-L1 Blockade in Chronic Hepadnaviral Infection

Jia Liu, Ejuan Zhang, Zhiyong Ma et al. · PLoS Pathogens · 2014 · 247 citations · Full text

Immunology, Hepatitis B Virus, Immunotherapy +17

Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway

Rajmohan Murali, Raghu Chandramohan, Inga Möller et al. · Oncotarget · 2015 · 131 citations · Full text

Engineering, Parallel Sequencing, Genetics +18

TERT Promoter Mutations Are Frequent in Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma

Klaus Griewank, Rajmohan Murali, Bastian Schilling et al. · PLoS ONE · 2013 · 102 citations · Full text

Tumor Biology, Somatic Variant, Non-melanoma Skin Cancer +15

Atypical fibroxanthoma and pleomorphic dermal sarcoma harbor frequent NOTCH1/2 and FAT1 mutations and similar DNA copy number alteration profiles

Klaus Griewank, Thomas Wiesner, Rajmohan Murali et al. · Modern Pathology · 2017 · 99 citations · Full text

Fat1 Mutations, Somatic Variant, Tumor Heterogeneity +10